ETANERCEPT (BIOLOGICAL RESPONSE MODIFIER) MODULATES CLINICAL, MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL PROFILE OF PSORIATIC DISEASE, BY ACTING ON VEGF, CTACK AND FACTOR VIII CUTANEOUS EXPRESSION: OPEN LABEL CLINICAL TRIAL / Campanati, Anna; Goteri, Gaia; Sabato, Simona; Offidani, Annamaria. - ELETTRONICO. - (2010), pp. 193-212.
ETANERCEPT (BIOLOGICAL RESPONSE MODIFIER) MODULATES CLINICAL, MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL PROFILE OF PSORIATIC DISEASE, BY ACTING ON VEGF, CTACK AND FACTOR VIII CUTANEOUS EXPRESSION: OPEN LABEL CLINICAL TRIAL.
CAMPANATI, Anna;GOTERI, Gaia;SABATO, SIMONA;OFFIDANI, ANNAMARIA
2010-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.